Skip to main content

What the FDA labels say about taking them together

Aspirin and ranibizumab

Ranibizumab's FDA label (Susvimo) of November 21, 2025 names aspirin in its warnings and precautions section; the aspirin label PlainMeds reads does not name ranibizumab. The ranibizumab label: “Patients on antithrombotic medication may be at increased risk of vitreous hemorrhage.”

Check it at the source: the aspirin FDA label on DailyMed (effective September 9, 2025); the ranibizumab FDA label on DailyMed (effective November 21, 2025, Genentech, Inc.).

What does the aspirin label say about ranibizumab?

Aspirin's label (effective September 9, 2025) does not name ranibizumab in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Medique Products Aspirin), Unifirst First Aid Corporation, effective September 9, 2025 (SPL set 9b28fed0-a993-ca72-e053-2995a90ac7fd), via openFDA; the full label on DailyMed

What does the ranibizumab label say about aspirin?

Susvimo label (Genentech, Inc., November 21, 2025), warnings and precautions

Patients on antithrombotic medication (e.g., oral anticoagulants, aspirin, nonsteroidal anti-inflammatory drugs) may be at increased risk of vitreous hemorrhage.

Source: FDA drug label (Susvimo, BLA761197), Genentech, Inc., effective November 21, 2025 (SPL set 9c6d9e2a-9a77-4d11-b692-de87cfde3444), via openFDA

Source: FDA drug label (LUCENTIS), Genentech, Inc., effective November 21, 2025 (SPL set de4e66cc-ca05-4dc9-8262-e00e9b41c36d), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Aspirin generic labelers
0Ranibizumab generic labelers
AspirinRanibizumab
Labeled forPain, Cough and cold, Fevern/a
Boxed warningNoNo
Pharmacy cost (NADAC)$0.0142 per tablet 81 mg tabletn/a
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?